Insempra completes $20 million financing to advance the development of bio-based ingredients.

In Germany, Insempra announced the successful completion of a $20 million Series A financing round.

Following an initial $15m seed round conducted in 2021, this financing round will enable Insempra, to continue building a technology platform that delivers high-performance sustainable ingredients for a wide range of industries, while supporting the company in the scale up of its technology scouting, development, and manufacturing capabilities.

Existing investors EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten and Acequia Capital participated in the round. New investors are the corporate venture of international FMCG giant Henkel, Henkel dx Ventures, Bayern Kapital and Alante Capital, the company said.

Jens Klein, founder, and CEO of Insempra, said: “We are grateful for the support of this group of investors who have recognized the potential of Insempra’s market-first approach and innovative technology platforms. Working in collaboration with nature, we will continue to expand our capacity to develop intrinsically sustainable materials that are superior in quality and will reduce our dependency on chemical industrialization processes.”

More on the story.